EUVIMEDDescobrir EUVIMED
Leserbrief

Curcumin supplementation as a complementary and alternative medicine for COVID ‐19 patients

Nader Aghakhani, Hamid Soraya iD

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8194 ↗

At a glance

Leserbrief in Phytotherapy Research, 2024. Written by Nader Aghakhani and 1 co-authors. Institution: Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran. Major MEDLINE topics: Curcumin, COVID-19 Drug Treatment, Complementary Therapies, Dietary Supplements. 24 references.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Subjects

MeSH terms (MEDLINE)

CurcuminCOVID-19 Drug TreatmentComplementary TherapiesDietary SupplementsHumansCOVID-19SARS-CoV-2

Substances

Curcumin

Authors and institutions

  • Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran.
  • Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran.
  • Experimental and Applied Pharmaceutical Research Center, Urmia University of Medical Sciences, Urmia, Iran.

ORCID profiles: Hamid Soraya

Cite

APA

Aghakhani, N., & Soraya, H. (2024). Curcumin supplementation as a complementary and alternative medicine for COVID ‐19 patients. Phytotherapy Research. https://doi.org/10.1002/ptr.8194

Vancouver

Aghakhani N, Soraya H. Curcumin supplementation as a complementary and alternative medicine for COVID ‐19 patients. Phytotherapy Research. 2024. doi:10.1002/ptr.8194

BibTeX
@article{Aghakhani2024,
  author = {Aghakhani, Nader and Soraya, Hamid},
  title = {Curcumin supplementation as a complementary and alternative medicine for COVID ‐19 patients},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8194}
}
Start for free →